Citation Impact
Citing Papers
Digitalization to achieve sustainable development goals: Steps towards a Smart Green Planet
2021 Standout
Person-centredness: Conceptual and historical perspectives
2007 Standout
Folic Acid Supplementation Mitigates Alzheimer’s Disease by Reducing Inflammation: A Randomized Controlled Trial
2016
Efficacy of Memantine for Agitation in Alzheimer’s Dementia: A Randomised Double-Blind Placebo Controlled Trial
2012
The Response of Agitated Behavior to Pain Management in Persons with Dementia
2013
Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial
2013
Parkinson disease
2017 Standout
2013 Alzheimer's disease facts and figures
2013 Standout
The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
2011 Standout
Rivastigmine for Alzheimer’s disease
2005
Risk of Death With Atypical Antipsychotic Drug Treatment for Dementia
2005
Oxidative Stress Hypothesis in Alzheimer's Disease
1997 Standout
Estimating the true global burden of mental illness
2016 Standout
Behavioral Disturbance in Dementia
2012
The Multidisciplinary Approach to Alzheimer's Disease and Dementia. A Narrative Review of Non-Pharmacological Treatment
2018
Alzheimer's disease
2011 Standout
A Controlled Naturalistic Study on a Weekly Music Therapy and Activity Program on Disruptive and Depressive Behaviors in Dementia
2010
Oxidative stress and the amyloid beta peptide in Alzheimer’s disease
2017 Standout
Psychedelics
2016 Standout
Nonmedical Influences on the Use of Cholinesterase Inhibitors in Dementia Care
2007
Dementia of the Alzheimer Type
2008
Quality of drug prescribing in older patients: is there a problem and can we improve it?
2009
A Double-Blind Placebo-Controlled Randomized Trial of <i>Melissa officinalis</i> Oil and Donepezil for the Treatment of Agitation in Alzheimer’s Disease
2011
Physicians’ practice and familiarity with treatment for agitation associated with dementia in Israeli nursing homes
2012
Efficacy and Adverse Effects of Atypical Antipsychotics for Dementia: Meta-analysis of Randomized, Placebo-Controlled Trials
2006
Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial
2011
Parkinson's disease
2015 Standout
Meta-Analysis of the Effectiveness of Atypical Antipsychotics for the Treatment of Behavioural Problems in Persons with Dementia
2007
Behavioral and Psychological Symptoms of Dementia
2012
Targeting and Managing Behavioral Symptoms in Individuals with Dementia: A Randomized Trial of a Nonpharmacological Intervention
2010
On the Discovery and Development of Pimavanserin: A Novel Drug Candidate for Parkinson’s Psychosis
2014
Rivastigmine for Alzheimer's disease
2000
Neuropathological Alterations in Alzheimer Disease
2011 Standout
Management of Neuropsychiatric Symptoms in People with Dementia
2010
Determinants of Quality of Life in Nursing Home Residents with Dementia
2010
Donepezil for the Treatment of Agitation in Alzheimer's Disease
2007
Use of drug treatments for Alzheimer's disease in France: a study on a national level based on the National Alzheimer's Data Bank (Banque Nationale Alzheimer)
2012
Acetylcholinesterase Inhibitors: Pharmacology and Toxicology
2013 Standout
The effect of exercise on behavioral and psychological symptoms of dementia: towards a research agenda
2011
STOPP/START criteria for potentially inappropriate prescribing in older people: version 2
2014 Standout
Prazosin for the Treatment of Behavioral Symptoms in Patients With Alzheimer Disease With Agitation and Aggression
2009
A randomized controlled trial of rivastigmine in patients with cognitive impairment no dementia because of cerebrovascular disease
2009
The Pathobiology of Vascular Dementia
2013 Standout
Cognitive Stimulation in Patients with Dementia: Randomized Controlled Trial
2013 Standout
Special Care Units and Traditional Care in Dementia: Relationship with Behavior, Cognition, Functional Status and Quality of Life - A Review
2013 Standout
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
2017 Standout
The amyloid state and its association with protein misfolding diseases
2014 Standout
Excess mortality from mental, neurological and substance use disorders in the Global Burden of Disease Study 2010
2014
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
2020 Standout
Assessment and management of behavioral and psychological symptoms of dementia
2015 Standout
The Determinants of Quality of Life of Nursing Home Residents with Young-Onset Dementia and the Differences between Dementia Subtypes
2017 Standout
Management of agitation and aggression associated with Alzheimer disease
2009
Nonpharmacologic Management of Behavioral Symptoms in Dementia
2012
Comprehensive Review on Alzheimer’s Disease: Causes and Treatment
2020 Standout
Alzheimer's disease
2017 Standout
Reviews: Current Concepts in Alzheimer's Disease: A Multidisciplinary Review
2008
Invited commentary on: Non-pharmacological interventions in dementia
2004
Dementia.
2012
Diagnosis and Treatment of Parkinson Disease
2020 Standout
Neue Ziele für die Photopharmakologie
2016 StandoutNobel
The Long-Term Effects of Conventional and Atypical Antipsychotics in Patients With Probable Alzheimer’s Disease
2013
2012 Alzheimer's disease facts and figures Alzheimer's Association ∗
2012 Standout
Parkinson’s disease dementia: what’s in a Lewy body?
2006
The Treatment of Alzheimer Disease
2008
Neuroleptic drugs in dementia: benefits and harm
2006
Guidelines for Adult Stroke Rehabilitation and Recovery
2016 Standout
The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
2018 Standout
Emerging Targets in Photopharmacology
2016 StandoutNobel
Rivastigmine for Alzheimer's disease
2015
Cholinesterase inhibitors for Alzheimer's disease
2006 Standout
Risk of Mortality Among Individual Antipsychotics in Patients With Dementia
2011
Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia
2013
Works of Simon Douglas being referenced
A Randomised, Blinded, Placebo-Controlled Trial in Dementia Patients Continuing or Stopping Neuroleptics (The DART-AD Trial)
2008
Brief Psychosocial Therapy for the Treatment of Agitation in Alzheimer Disease (The CALM-AD Trial)
2009
The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial
2009
Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial
2005
Non-pharmacological interventions in dementia
2004